HSCB and neoplasm: The expression of DNAJC20 (better prognosis) was significantly lower in tumor tissue (log2 Fold Change (FC) = 0,7; p = 0,0251), whereas HSP90AA1, CCT2, CCT6A (unfavorable prognosis) were upregulated in tumors (HSP90AA1 log2 FC = 3,4; p < 0,0001; CCT2 log2 FC = 0,78; p < 0,0001; CCT6A log2 FC = 0,68; p < 0,0001, respectively).